Provided by Tiger Fintech (Singapore) Pte. Ltd.

XILIO THERAPEUTICS, INC.

0.7310
+0.02102.96%
Post-market: 1.230.4990+68.26%19:59 EDT
Volume:10.98M
Turnover:9.15M
Market Cap:37.85M
PE:-0.88
High:0.7499
Open:0.7100
Low:0.6975
Close:0.7100
Loading ...
Jan 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 06, 2022

Major Issues Report

8-K - Current report
Dec 02, 2021

Major Issues Report

8-K - Current report
Dec 02, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 05, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 05, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 05, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 03, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Oct 27, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2021

Major Issues Report

8-K - Current report
Oct 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Oct 20, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 19, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 19, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 18, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 18, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 01, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Oct 01, 2021

Correspondence

CORRESP [Cover] - Correspondence